Current Treatment of Nausea and Vomiting Associated with Gastroparesis

Antiemetics, Prokinetics, Tricyclics

Jeremy Stapleton, John Wo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Gastroparesis is a symptomatic chronic disorder characterized by delayed gastric emptying without a mechanical obstruction. Gastroparesis is most often associated with diabetes, gastric surgery, and systemic disorders affecting the neuromuscular control of the stomach. However, no underlying etiology can be found in up to 40% of patients, a condition referred to as idiopathic gastroparesis. Due to the numerous potential etiologies and the highly variable clinical manifestations, the management of gastroparesis is particularly challenging. The purpose of this review is to provide an update on the use of antiemetics, prokinetics, and tricyclics for the treatment for nausea and vomiting associated with gastroparesis.

Original languageEnglish (US)
Pages (from-to)57-72
Number of pages16
JournalGastrointestinal Endoscopy Clinics of North America
Volume19
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Gastroparesis
Antiemetics
Nausea
Vomiting
Stomach
Therapeutics
Gastric Emptying

Keywords

  • Antiemetics
  • Gastroparesis
  • Nausea
  • Prokinetics
  • Tricyclics
  • Vomiting

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Current Treatment of Nausea and Vomiting Associated with Gastroparesis : Antiemetics, Prokinetics, Tricyclics. / Stapleton, Jeremy; Wo, John.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 19, No. 1, 01.2009, p. 57-72.

Research output: Contribution to journalArticle

@article{44ee716d459f4a6eb0e00f6bb82e97b4,
title = "Current Treatment of Nausea and Vomiting Associated with Gastroparesis: Antiemetics, Prokinetics, Tricyclics",
abstract = "Gastroparesis is a symptomatic chronic disorder characterized by delayed gastric emptying without a mechanical obstruction. Gastroparesis is most often associated with diabetes, gastric surgery, and systemic disorders affecting the neuromuscular control of the stomach. However, no underlying etiology can be found in up to 40{\%} of patients, a condition referred to as idiopathic gastroparesis. Due to the numerous potential etiologies and the highly variable clinical manifestations, the management of gastroparesis is particularly challenging. The purpose of this review is to provide an update on the use of antiemetics, prokinetics, and tricyclics for the treatment for nausea and vomiting associated with gastroparesis.",
keywords = "Antiemetics, Gastroparesis, Nausea, Prokinetics, Tricyclics, Vomiting",
author = "Jeremy Stapleton and John Wo",
year = "2009",
month = "1",
doi = "10.1016/j.giec.2008.12.008",
language = "English (US)",
volume = "19",
pages = "57--72",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Current Treatment of Nausea and Vomiting Associated with Gastroparesis

T2 - Antiemetics, Prokinetics, Tricyclics

AU - Stapleton, Jeremy

AU - Wo, John

PY - 2009/1

Y1 - 2009/1

N2 - Gastroparesis is a symptomatic chronic disorder characterized by delayed gastric emptying without a mechanical obstruction. Gastroparesis is most often associated with diabetes, gastric surgery, and systemic disorders affecting the neuromuscular control of the stomach. However, no underlying etiology can be found in up to 40% of patients, a condition referred to as idiopathic gastroparesis. Due to the numerous potential etiologies and the highly variable clinical manifestations, the management of gastroparesis is particularly challenging. The purpose of this review is to provide an update on the use of antiemetics, prokinetics, and tricyclics for the treatment for nausea and vomiting associated with gastroparesis.

AB - Gastroparesis is a symptomatic chronic disorder characterized by delayed gastric emptying without a mechanical obstruction. Gastroparesis is most often associated with diabetes, gastric surgery, and systemic disorders affecting the neuromuscular control of the stomach. However, no underlying etiology can be found in up to 40% of patients, a condition referred to as idiopathic gastroparesis. Due to the numerous potential etiologies and the highly variable clinical manifestations, the management of gastroparesis is particularly challenging. The purpose of this review is to provide an update on the use of antiemetics, prokinetics, and tricyclics for the treatment for nausea and vomiting associated with gastroparesis.

KW - Antiemetics

KW - Gastroparesis

KW - Nausea

KW - Prokinetics

KW - Tricyclics

KW - Vomiting

UR - http://www.scopus.com/inward/record.url?scp=68649091505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68649091505&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2008.12.008

DO - 10.1016/j.giec.2008.12.008

M3 - Article

VL - 19

SP - 57

EP - 72

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 1

ER -